Inventor
JERUSSI Thomas
US11 patents
⚠️ This page may combine multiple inventors who share the name “JERUSSI Thomas”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUNOVION PHARMACEUTICALS INC
7 patentsUS9072699B2Jul 7, 2015
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
SUNOVION PHARMACEUTICALS INC4 citations84
US8344030B2Jan 1, 2013
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
SUNOVION PHARMACEUTICALS INC3 citations73
US10702486B2Jul 7, 2020
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
SUNOVION PHARMACEUTICALS INC0 citations52
US10328036B2Jun 25, 2019
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
SUNOVION PHARMACEUTICALS INC0 citations52
US9907764B2Mar 6, 2018
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
SUNOVION PHARMACEUTICALS INC0 citations52
US9498452B2Nov 22, 2016
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
SUNOVION PHARMACEUTICALS INC0 citations52
US8658700B2Feb 25, 2014
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
SUNOVION PHARMACEUTICALS INC0 citations52
SEPRACOR INC
3 patentsUS7790772B2Sep 7, 2010
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
SEPRACOR INC15 citations92
US7589237B2Sep 15, 2009
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
SEPRACOR INC14 citations92
US7423179B2Sep 9, 2008
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
SEPRACOR INC12 citations92